Learn how Cardiovascular Outcomes Trials (CVOTs) were designed and how to put them into context.
- Understand key elements in how CVOTs were designed, including key differences in patient populations and treatment duration.
- Understand post-hoc attempts to understand effects in patients with established disease and in patients with risk factors.
- Describe key takeaways and how these results are impacting treatment guidelines and future directions of research.
Free to members and nonmembers
This webinar is part of a series of educational activities presented by AADE in association with AstraZeneca-US Medical Affairs, CVMD Division. This webinar is educational in nature and contains no promotional or product information. CE credit is not available for this activity.